Abstract : We developed a method for the determination of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in human blood using a high-performance liquid chromatograph (HPLC). In this method, UMP (uridine 5'-monophosphate disodium salt) was used as a substrate and assay solutions were directly prepared from whole blood. Uridine formed by the enzyme reaction of P5N was determined spectrophotometrically at 260 nm after separation from the substrate and blood components by HPLC. The optimum pH of this reaction was 7.5. This HPLC method was very rapid and simple compared to the conventional method, because of eliminating the need for dialysis of erythrocyte lysate prior to the assay.
INTRODUCTION
Erythrocyte pyrimidine 5'-nucleotidase (P5N) is an enzyme which catalyses the dephosphorylation of pyrimidine nucleotides, i.e., uridine and cytidine 5'-monophosphates (UMP and CMP) . Its presence in erythrocytes was first reported by Valentine et al.1) 
in 1974.
Several investigators2-8) have indicated that.erythrocyte P5N activity is strongly inhibited by lead in viva and the degree of its inhibition has a close correlation with the concentration of lead in blood. These reports suggest that the erythrocyte P5N activity test is useful as an indicator of lead exposure or lead poisoning.
The erythrocyte P5N activity has been measured in most cases according to the conventional method of Paglia and Valentine,9) in which the amount of inorganic phosphate (Pi) formed in the enzyme assay is determined colorimetrically.
However, this method is very time-consuming in large-scale routine analysis, because it requires dialysis of erythrocyte lysate prior to the enzyme assay, to remove Pi which is already present in erythrocytes.
On the other hand, Sakai et al.10) have developed a method for the determination of erythrocyte P5N activity using a high-performance liquid chromatograph (HPLC).
In the latter method, the preparation of the enzyme was carried out using washed erythrocytes, and the product (uridine) formed by the enzyme reaction was separated from the UMP substrate and determined.
In the present study, we further simplified this HPLC method by using whole blood for the preparation of enzyme solution instead of washed erythrocytes. In addition, we investigated the reliability on UMP and CMP as the substrate, when the HPLC method was adopted for determining erythrocyte P5N activity. In conclusion, the HPLC method for the determination of P5N activity becomes more rapid and simpler, when the whole blood instead of the washed erythrocytes is used for enzyme preparation and UMP instead of CMP is used as the substrate.
MATERIALS AND METHODS
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